CHA Hospital and CHA Bio Group, Open Recruitment for New Graduates and Juniors... Until the 13th of Next Month

Junior Recruitment Process for Candidates with 1 to 3 Years of Experience

Cha Hospital and Cha Bio Group announced on the 26th that they will conduct a 2023 recruitment for new and junior employees.

This recruitment will be carried out across seven institutions including Bundang Cha Hospital, Medical Foundation, Cha Biotech, CMG Pharmaceutical Cha Vaccine Research Institute, and Cha Comprehensive Research Institute, Future Medicine Research Institute, among others within the Cha Bio Group affiliates. The job categories include research and development, administrative office work, IT (computing), and construction.

Following last year, this year’s recruitment will also conduct a junior track alongside the new employee track to select candidates with high job suitability. The junior track targets candidates with 1 to 3 years of relevant experience.

The new and junior recruitment process includes document screening, aptitude and personality tests, and interviews, followed by the announcement of final successful candidates. Applicants wishing to apply can submit their applications on the Cha Hospital and Bio Group recruitment website from the 26th until the 13th of next month.

Cha Hospital and Bio Group is a bio-healthcare group based on a global network of 90 institutions across 7 countries. Cha Hospital and Bio Group plans to strengthen its research and development (R&D) capabilities and secure new business growth engines by recruiting highly potential talents.

Cha Hospital and Bio Group operates the 'R&D Researcher Doctoral Program' tailored to optimize talent development according to the specific research fields of each job, and the 'Cha Bio MBA' program, a Master of Business Administration degree course combining MBA and bio-healthcare curricula. Additionally, the group runs a 'Global Expert System' that selects outstanding talents within the group and provides overseas training opportunities in countries such as the United States and Australia. According to internal regulations, employees receive medical expense benefits, and a flexible work system is operated to establish a family-friendly corporate culture.

Founded in 1960, Cha Hospital has a global medical institution network including locations in Gangnam, Bundang, Ilsan, Gumi, Daegu in Korea, as well as the United States and Australia. Centered around Cha University of Medicine and Science, it has achieved results in infertility reproductive medicine, general hospitals, health screening centers, and future-oriented hospitals.

Cha Bio Group consists of three listed companies led by Cha Biotech, CMG Pharmaceutical, and Cha Vaccine Research Institute, as well as Cha Healthcare, Cha Meditech, Cha Bio F&C, Cha Cares, Seoul CRO, and Solidus Investment. The Comprehensive Research Institute and Future Medicine Research Institute are also expanding their R&D areas in the cell and gene (Cell&Gene) field.

Recruitment poster of CHA Hospital and Bio Group. [Image provided by CHA Bio Group]

This content was produced with the assistance of AI translation services.